Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris

This publication has 24 references indexed in Scilit:

• Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris
  The American Journal of Cardiology, 1992
• Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay
  Journal of Pharmaceutical and Biomedical Analysis, 1991
• Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle
  The American Journal of Cardiology, 1991
• A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo
  Journal of the American College of Cardiology, 1990
• Rate-Dependent Class III Antiarrhythmic Action, Negative Chronotropy, and Positive Inotropy of a Novel Ik Blocking Drug, UK-68,798
  Journal of Cardiovascular Pharmacology, 1990
• Recent advances in understanding the mechanisms of drug-induced torsades de pointes arrhythmias
  The American Journal of Cardiology, 1989
• Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies.
  Journal of Clinical Investigation, 1988
• Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone
  American Heart Journal, 1987
• STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
  The Lancet, 1986
• Long-term recording of monophasic action potentials from human endocardium
  The American Journal of Cardiology, 1983